Overview

Olanzapine Versus Aripiprazole in the Treatment of Acutely Ill Patients With Schizophrenia

Status:
Completed
Trial end date:
2006-08-01
Target enrollment:
Participant gender:
Summary
The purposes of this study are to assess similarities and differences in the efficacy (how well the drug works), safety, and side effects of olanzapine and aripiprazole in patients with schizophrenia, schizoaffective disorder, or schizophreniform disorder.
Phase:
Phase 4
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Aripiprazole
Olanzapine